Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04861038 · ClinicalTrials.gov registry record · NA

Study Using Negative Pressure to Reduce Apnea

A NA study of Sleep Apnea, Obstructive and Apnea, Sleep, sponsored by Sommetrics.

Active
Registry status
NA
Development phase
900
Enrollment target
15
Study locations

NCT04861038: Active NA study of Sleep Apnea, Obstructive and Apnea, Sleep, sponsored by Sommetrics.

NCT04861038 is a NA study of Sleep Apnea, Obstructive and Apnea, Sleep that is active but no longer recruiting, run by Sommetrics. The registered enrollment target is 900 participants, above the 242-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (272% higher). The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04861038, a NA study of Sleep Apnea, Obstructive and Apnea, Sleep, is active but no longer recruiting, sponsored by Sommetrics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
15
Study locations

Study Summary

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adult subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) therapy.

Interventions

  • DEVICE aerSleep II

Study Locations (15)

Ohio

  • The MetroHealth System - Cleveland
  • Cleveland Clinic Foundation - Cleveland
  • The Ohio State University - Columbus

California

  • Infinitive Bioresearch - Los Angeles
  • BetterNight - San Diego

Pennsylvania

  • Thomas Jefferson University - Philadelphia
  • UPMC - Pittsburgh

South Carolina

  • Bogan Sleep Consultants - Columbia
  • BioSerenity - Columbia

Arizona

  • University of Arizona - Tucson

Arkansas

  • Preferred Research Partners - Little Rock

Colorado

  • Delta Waves - Colorado Springs

Florida

  • Baptist Hospital - Miami

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2021-11-29
Est. Completion 2025-12
Phase NA
Sommetrics

3 total trials

What the registry record for NCT04861038 still lists

NCT04861038 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 242-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (272% higher).

The record links to 2 conditions, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which aerSleep II is the first listed.

NCT04861038 lists 15 locations in 10 states (Ohio, California, Pennsylvania).

Frequently Asked Questions

What is clinical trial NCT04861038 about?

NCT04861038 is a clinical study titled "Study Using Negative Pressure to Reduce Apnea". The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive Sleep Apnea (OSA) over 24 weeks of home use in spontaneously breathing adult subjects who are intolerant of Continuous Positive Airway Pressure (CPAP) t...

What is the current status of trial NCT04861038?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2021-11-29. Estimated completion is 2025-12.

What conditions does trial NCT04861038 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive, Apnea, Sleep.

What interventions are being tested in trial NCT04861038?

The interventions under investigation include: aerSleep II (DEVICE).

Who is sponsoring clinical trial NCT04861038?

This trial is sponsored by Sommetrics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04861038 being conducted?

This trial has 15 study locations across Arizona, Arkansas, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04861038's enrollment target sits among peer trials

900 3rd of 45 higher than 43 of 45 other Sleep Apnea, Obstructive trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04861038, the US trial registry maintained by the National Library of Medicine. NCT04861038 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.